Serum sodium levels and related treatment-emergent adverse events during eslicarbazepine acetate use in adults with epilepsy.
Robert T WechslerRodney A RadtkeMichael SmithDavid G VosslerLaura StromEugen TrinkaHailong ChengTodd GrinnellDavid BlumMariana VieiraJoana MoreiraFrancisco RochaPublished in: Epilepsia (2019)
Reductions in serum sodium concentrations and hyponatremia-related TEAEs occurred in a small number of patients taking ESL. Suspected hyponatremia should be confirmed and monitored via [Na+ ] measurements.